Quest Diagnostics appoints Benjamin Beauvalot as strategy and M&A chief
Go back to Quest Diagnostics appoints Benjamin Beauvalot as strategy and M&A chief| Quest Diagnostics (NYSE: DGX) | Delayed: 237.54 +1.70 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $235.84 | 52 Week High | $86.85 | |||
| Open | $237.66 | 52 Week Low | $59.66 | |||
| Day High | $238.56 | P/E | 44.73 | |||
| Day Low | $235.32 | EPS | $5.31 | |||
| Volume | 263,951 | |||||

